Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Molecular Therapy. Nucleic Acids|March 4, 2025
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAsJason M Myers, Jack M SullivanAdvances in Experimental Medicine and Biology|December 30, 2019
A Discovery with Potential to Revitalize Hammerhead Ribozyme Therapeutics for Treatment of Inherited Retinal DegenerationsAlexandria J Trujillo, Jason M Myers, Zahra S Fayazi, et al.Investigative Ophthalmology & Visual Science|November 10, 2015
A Novel, Real-Time, In Vivo Mouse Retinal Imaging SystemMark C Butler, Jack M SullivanExperimental Eye Research|January 25, 2011
Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agentsTiffany A Kolniak, Jack M SullivanJournal of Visualized Experiments : Jove|November 20, 2018
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy ResearchMark C Butler, Jack M SullivanThe Journal of General Physiology|May 30, 2002
HEK293S cells have functional retinoid processing machineryLioubov I Brueggemann, Jack M SullivanExperimental Eye Research|May 29, 2016
A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targetsEdwin H Yau, Mark C Butler, Jack M SullivanInvestigative Ophthalmology & Visual Science|October 17, 2009
A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agentsMark C Butler, Patrick N Itotia, Jack M SullivanInvestigative Ophthalmology & Visual Science|July 18, 2017
Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate RibozymeBeau R Froebel, Alexandria J Trujillo, Jack M SullivanOphthalmic Genetics|January 15, 2024
RTN4IP1-associated non-syndromic optic neuropathy and rod-cone dystrophyPriya R Gupta, Kaitlin O'Connell, Jack M Sullivan, et al.Pageof 4